Skip navigation

One Nucleus Member Vacancies

Ref: 882223 Signal Detection Manager EU

Our client is a leading life science organisation focused on both the discovery of new molecules and is also a significant player in the generics market globally.

By PiR Resourcing, 16 January 2015

REF: 882220 Business Development Manager, Western Europe

Our client is a leading life science organisation focused on both the discovery of new molecules and is also a significant player in the generics market globally.

By PiR Resourcing, 16 January 2015

Laboratory Manager - Cell Culture

Laboratory Manager - Cell Culture Cambridge Fixed Term Contract - 2 years Excellent salary & benefits

By Stuart Nunn, 16 January 2015

Scientist

This is an exceptional opportunity to join a fast moving biotechnology company and to participate in shaping a future leader in the field of antibody therapeutics.

By B M, 16 January 2015

Ref: 882221 Pharmacovigilance Compliance Manager EU

Our client is a leading life science organisation focused on both the discovery of new molecules and is also a significant player in the generics market globally.

By PiR Resourcing, 16 January 2015

HTS automation specialist (MedImmune)

The jobholder will play an important role in early drug development programmes by supporting the analytical characterisation of novel proteins (from peptides to antibodies) for batch release and stability assessment.

16 January 2015

Ref: 882224 QA Lead for Pharmacovigilance

Our client is a leading life science organisation focused on both the discovery of new molecules and is also a significant player in the generics market globally.

By PiR Resourcing, 16 January 2015

Senior QC Analyst

Senior QC Analyst Cambridge Fixed Term Contract - 2 years Excellent salary & benefits

By Stuart Nunn, 16 January 2015

Team Leader - Clinical Pathology

CLINICAL PATHOLOGY TEAM LEADER CAMBRIDGE, CAMBRIDGESHIRE EXCELLENT SALARY AND BENEFITS

By Stuart Nunn, 15 January 2015

Senior Scientist

Horizon Discovery is a UK biotechnology company that combines a long scientific heritage in translational research with a world-leading gene editing platform based upon homologous recombination.

By Kamila Bienas, 14 January 2015

<< Previous   Page 2 of 11   Next >>